Full Product Name
Rabbit Anti-STRA6 antibody
Product Synonym Names
Protein A-Purified Rabbit Polyclonal Antibody (Pab)
Product Gene Name
anti-STRA6 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q9BX79
Form/Format
0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Antigen Source
KLH conjugated synthetic peptide derived from Human STRA6
Antigen Type
Synthesized Peptide
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-STRA6 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-STRA6 antibody
Developmental Biology; Metabolism; Signal Transduction; Stem Cells
Applications Tested/Suitable for anti-STRA6 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-STRA6 antibody
WB ~~ 1:100-1:500
IHC ~~ 1:50
Western Blot (WB) of anti-STRA6 antibody
Tissue/cell:Placenta,primary antibody 1:300 overnight.

Immunohistochemistry (IHC) of anti-STRA6 antibody
human kidney tissue; 4% Paraformaldehyde-fixed and paraffin-embedded; Antigen retrieval: citrate buffer (0.01M, pH 6.0), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum) at 37 degree C for 20 min; Incubation: Anti-STRA6 Polyclonal Antibody, Unconjugated 1:200, overnight at 4 degree C, followed by conjugation to the secondary antibody and DABstaining.

NCBI/Uniprot data below describe general gene information for STRA6. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001136089.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001142617.1
[Other Products]
UniProt Primary Accession #
Q9BX79
[Other Products]
UniProt Secondary Accession #
Q6PJF8; Q71RB9; Q7L9G1; Q7Z3U9; Q8TB21; A8K7F1; B7Z5M9; B7Z862; D3DW54; F5GYI8; I3L1G8[Other Products]
UniProt Related Accession #
Q9BX79[Other Products]
NCBI Official Full Name
stimulated by retinoic acid gene 6 protein homolog isoform a
NCBI Official Synonym Full Names
stimulated by retinoic acid 6
NCBI Official Symbol
STRA6 [Similar Products]
NCBI Official Synonym Symbols
MCOPS9; MCOPCB8; PP14296
[Similar Products]
NCBI Protein Information
stimulated by retinoic acid gene 6 protein homolog
UniProt Protein Name
Stimulated by retinoic acid gene 6 protein homolog
Protein Family
Stimulated by retinoic acid gene 6 protein
UniProt Gene Name
STRA6 [Similar Products]
UniProt Entry Name
STRA6_HUMAN
NCBI Summary for STRA6
The protein encoded by this gene is a membrane protein involved in the metabolism of retinol. The encoded protein acts as a receptor for retinol/retinol binding protein complexes. This protein removes the retinol from the complex and transports it across the cell membrane. Defects in this gene are a cause of syndromic microphthalmia type 9 (MCOPS9). Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
UniProt Comments for STRA6
STRA6: May act as a high-affinity cell-surface receptor for the complex retinol-retinol binding protein (RBP/RBP4). Acts by removing retinol from RBP/RBP4 and transports it across the plasma membrane, where it can be metabolized. This mechanism does not depend on endocytosis. Binds to RBP/RBP4 with high affinity. Increases cellular retinol uptake from the retinol-RBP complex. Defects in STRA6 are the cause of microphthalmia syndromic type 9 (MCOPS9); also called Matthew-Wood syndrome or Spear syndrome. Microphthalmia is a clinically heterogeneous disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS9 is a rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia. Mutations in STRA6 may be a cause of isolated colobomatous microphthalmia, a disorder of the eye characterized by an abnormally small ocular globe. 4 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, multi-pass; Membrane protein, integral
Chromosomal Location of Human Ortholog: 15q24.1
Cellular Component: protein complex; plasma membrane; integral to membrane
Biological Process: developmental growth; phototransduction, visible light; blood vessel development; adrenal gland development; neuromuscular process; heart development; ear development; digestive tract morphogenesis; learning; vocal learning; female genitalia development; nose morphogenesis; smooth muscle development; positive regulation of behavior; artery morphogenesis; retinoic acid metabolic process; feeding behavior; kidney development; cognition; retinoid metabolic process; alveolus development; embryonic gut development; lung development
Disease: Microphthalmia, Syndromic 9
Research Articles on STRA6
1. These data establish that holo-RBP and its receptor STRA6 are potent oncogenes and suggest that the pathway is a novel target for therapy of some human cancers.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.